Excess chemical potential of thiophene in [C4MIM] [BF4, Cl,Br, CH3COO] ionic liquids,determined by molecular simulations

The excess chemical potential of thiophene in imidazolium-based ionic liquids [C₄mim][BF₄], [C₄mim][Cl], [C₄mim][Br], and [C₄mim][CH₃COO] were determined by means of molecular dynamics in conjunction with free energy perturbation techniques employing non-polarizable force fields at 300 K and 343.15 K. In addition, energetic and structural analysis were performed such as: interaction energies, averaged noncovalent interactions, radial, and combined distribution functions. The results from this work revealed that the ionic liquids (ILs) presenting the most favorable excess chemical potentials ([C₄mim][BF₄], [C₄mim][CH₃COO]) are associated with the strongest energetic interaction between the thiophene molecule and the ionic liquid anion, and with the weakest energetic interaction between the thiophene molecule and the ionic liquid cation.

Excess chemical potential of thiophene in imidazolium-based ionic liquids [C₄mim][BF₄], [C₄mim][Cl], [C₄mim][Br], and [C₄mim][CH₃COO] determined by molecular simulations.

In order to consider polarizability effects, not included in the classical forcefields, ab initio molecular dynamics (AIMD) were carried to elucidate a more representative molecular environment. The radial distribution functions (RDF) obtained from the AIMD indicated that the thiophene molecule finds the IL anions at closer distances than the imidazolium ring cation; also, the ionic liquids [C₄mim][BF₄] and [C₄mim][CH₃COO] presented more defined RDF peaks for the sulfur atom paired with hydrogen atoms within the imidazolium ring, in comparison with the thiophene–anion pair distributions, and the inverse RDF phenomena were observed in the other two ILs. Furthermore, the combined distribution functions signaled a series of interactions between thiophene and IL cation, including π–π thiophene–cation stacking (face to face, offset and edge to face), thiophene-alkyl chain interactions and hydrogen bonding between thiophene and the IL anion.The averaged noncovalent interactions determined from ab initio molecular dynamic trajectories showed that most of the interactions between the thiophene and IL ions are not strong; nevertheless, these interactions, according to the thermal fluctuation index, are stable throughout the entire simulation time.     

Organic–inorganic hybrid [NH3(CH2)6NH3]ZnBr4 crystal: structural characterization,phase transitions,thermal properties,and structural dynamics

Organic–inorganic hybrid [NH₃(CH₂)₆NH₃]ZnBr₄ crystals were prepared by slow evaporation; the crystals had a monoclinic structure with space group P2₁/c and lattice constants a = 7.7833 Å, b = 14.5312 Å, c = 13.2396 Å, β = 90.8650°, and Z = 4. They underwent two phase transitions, at 370 K (T_C1) and 430 K (T_C2), as confirmed by powder X-ray diffraction patterns at various temperatures; the crystals were stable up to 600 K. The nuclear magnetic resonance spectra, obtained using the magic-angle spinning method, demonstrated changes in the ¹H and ¹³C chemical shifts were observed near T_C1, indicating changing structural environments around ¹H and ¹³C. The spin–lattice relaxation time, T_1ρ, increased rapidly near T_C1 suggesting very large energy transfer, as indicated by a large thermal displacement around the ¹³C atoms of the cation. However, the environments of ¹H, ¹⁴N, and C1 located close to NH₃ in the [NH₃(CH₂)₆NH₃] cation did not influence it significantly, indicating a minor change in the N–H⋯Br hydrogen bond with the coordination geometry of the ZnBr₄ anion. We believe that the information on the physiochemical properties and thermal stability of [NH₃(CH₂)₆NH₃]ZnBr₄, as discussed in this study, would be key to exploring its application in stable, environment friendly solar cells.

Organic–inorganic hybrid [NH₃(CH₂)₆NH₃]ZnBr₄ crystals were prepared by slow evaporation; the crystals had a monoclinic structure with space group P2₁/c and lattice constants a = 7.7833 Å, b = 14.5312 Å, c = 13.2396 Å, β = 90.8650°, and Z = 4.     

Red/green-light emission in continuous dielectric phase transition materials: [Me3NVinyl]2[MnX4] (X = Cl,Br)

The luminescence of dielectric phase transition materials is one important property for technological applications, such as low-energy electron excitation. The combination of dielectric phase transitions and luminescence within organic–inorganic hybrids would lead to a new type of luminescent dielectric phase transition multifunctional material. Here, we report two novel A₂BX₄ organic–inorganic hybrid complexes [Me₃NVinyl]₂[MnCl₄] 1 and [Me₃NVinyl]₂[MnBr₄] 2, ([Me₃NVinyl] = trimethylvinyl ammonium cation). The complexes 1 and 2 were found to undergo continuous reversible phase transitions as well as switch dielectric phase transitions. Strikingly, intensive red luminescence and green luminescence were obtained under UV excitation respectively to reveal potential application of the two complexes in multi-functional materials along with dielectric switches and so on.

The luminescence of dielectric phase transition materials is one important property for technological applications, such as low-energy electron excitation.     

Thermal,ferroelastic, and structural properties near phase transitions of organic–inorganic perovskite type [NH3(CH2)3NH3]CdBr4 crystals

Hybrid perovskites have potential applications in several electrochemical devices such as supercapacitors, batteries, and fuel cells. Therefore, we studied the thermal behavior and structural dynamics of organic–inorganic hybrid perovskite [(NH₃)(CH₂)₃(NH₃)]CdBr₄ crystals near phase transition temperatures, T_C2 (=328 K) and T_C1 (=363 K), which are correlated to the structural dynamics of cations and anions. The structural geometry and molecular dynamics with emphasis on the role of the [(NH₃)(CH₂)₃(NH₃)] cation and CdBr₆ anion were discussed in terms of MAS ¹H NMR, MAS ¹³C NMR, ¹⁴N NMR, and ¹¹³Cd NMR as a function of the temperature. The environments surrounding ¹H, ¹³C, ¹⁴N, and ¹¹³Cd are investigated near T_C1 and T_C2 using these results. Spin–lattice relaxation times T_1ρ were discussed in terms of the change in temperature. The discontinuous changes of ¹H T_1ρ and ¹³C T_1ρ near T_C1 are consistent with the change of the lattice constant. Shorter T_1ρ values at high temperature indicate that ¹H and ¹³C in the organic chains are more flexible at these temperatures. Based on these results, the physicochemical properties of the cation and anion during the III–II–I phase transitions were discussed. This study was conducted to improve the relatively weak thermal stability compared to the high efficiency for a variety of applications.

We studied the thermal behavior and structural dynamics of [NH₃(CH₂)₃NH₃]CdBr₄ near phase transition temperatures.     

Investigation of the thermal properties of phase change materials encapsulated in capped carbon nanotubes using molecular dynamics simulations

Due to the high demand for clean, economic, and recyclable energy, phase change materials (PCMs) have received significant attention in recent years. To improve the performance of PCMs, they are confined in micro- and nano-capsules composed of organic or inorganic materials. In this study, encapsulated phase change material (EPCM) systems were constructed with paraffin molecules as the core material and capped carbon nanotubes (CNTs) as the shell. We investigated the effects of different parameters including CNT diameter, length, and chirality and the length of the alkane molecule chain. We also investigated metal nanocluster-enhanced PCM systems via the addition of Cu, Ag, and Al clusters to the EPCM systems. Different thermodynamic, dynamic, and structural properties including configurational energy, melting range, mean square displacement, self-diffusion coefficient, radial distribution function (RDF), and average end-to-end distance of the confined molecules were examined. We also investigated the effect of metal doping in CNT on the different properties of the confined PCM. The results indicated that a longer CNT has a lower melting point than the normal CNT system. It was also observed that the bigger (30,0) CNT, (14,14) armchair CNT, and icosane systems have higher melting ranges than the normal (25,0) system. The metal cluster systems also have a lower starting melting point than the normal system. Furthermore, it was found that the Al cluster system has the lowest starting melting point among the studied systems.

Nanocluster enhanced PCM and metal doped CNT PCM systems have lower melting points than the normal system.     

Effect of methylene chain length of perovskite-type layered [NH3(CH2)nNH3]ZnCl4 (n = 2, 3, and 4) crystals on thermodynamic properties,structural geometry,and molecular dynamics

The structure of organic–inorganic perovskite [NH₃(CH₂)₄NH₃]ZnCl₄ was determined; the lattice constants with monoclinic structure were determined to be a = 7.2527 Å, b = 8.1101 Å, c = 10.3842 Å, and β = 80.3436°. The crystal was almost thermally stable up to approximately 560 K. The endothermic peaks at 481 K and 506 K were assigned to the phase transition of the material. In addition, the structural characteristics and molecular dynamics of the cation were studied via magic angle spinning nuclear magnetic resonance experiments. Based on the results, the effects of the length of the CH₂ group in the cation of the [NH₃(CH₂)_nNH₃]ZnCl₄ (n = 2, 3, and 4) crystals were considered. Regardless of whether n was even or odd, the differences in the thermal and physical properties were minimal. Moreover, a difference in molecular motion relative to the length of the cation was observed only at high temperatures. These results provide useful information about the thermal stability and molecular dynamics of [NH₃(CH₂)_nNH₃]ZnCl₄ crystals and are expected to facilitate potential applications of such compounds in supercapacitors, batteries, and fuel cells.

¹H NMR spin–lattice relaxation times T_1ρ of [NH₃(CH₂)_nNH₃]ZnCl₄ (n = 2, 3, and 4) as a function of inverse temperature. The solid lines represent activation energy.     

Thermal and structural properties,and molecular dynamics in organic–inorganic hybrid perovskite (C2H5NH3)2ZnCl4

The thermal and structural properties and molecular dynamics of layered perovskite-type (C₂H₅NH₃)₂ZnCl₄ are investigated by differential scanning calorimetry, thermogravimetric analysis, and magic angle spinning nuclear magnetic resonance spectroscopy. The thermal properties and phase transitions are studied. Additionally, the Bloembergen–Purcell–Pound (BPP) curves for the ¹H spin–lattice relaxation time T_1ρ in the C₂H₅NH₃ cation and for the ¹³C T_1ρ in C₂H₅ are shown to have minima as a function of inverse temperature. This observation implies that these curves represent the rotational motions of ¹H and ¹³C in the C₂H₅NH₃ cation. The activation energies for ¹H and ¹³C in the C₂H₅NH₃ cation are obtained; the molecular motion of ¹H is enhanced at the C-end and N-end of the organic cation, and that at the carbons of the main chain is not as free as that for protons at the C-end and N-end.

The thermal and structural properties and molecular dynamics of layered perovskite-type (C₂H₅NH₃)₂ZnCl₄ are investigated by DSC, TGA, and MAS NMR spectroscopy.     

AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties

The vanilloid receptor 1 (VR1 or TRPV1) is a membrane-bound, nonselective cation channel expressed by peripheral sensory neurons. TRPV1 antagonists produce antihyperalgesic effects in animal models of inflammatory and neuropathic pain. Here, we describe the in vitro and in vivo pharmacology of a novel TRPV1 antagonist, AMG 9810, (E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide. AMG 9810 is a competitive antagonist of capsaicin activation (IC50 value for human TRPV1, 24.5 +/- 15.7 nM; rat TRPV1, 85.6 +/- 39.4 nM) and blocks all known modes of TRPV1 activation, including protons (IC50 value for rat TRPV1, 294 +/- 192 nM; human TRPV1, 92.7 +/- 72.8 nM), heat (IC50 value for rat TRPV1, 21 +/- 17 nM; human TRPV1, 15.8 +/- 10.8 nM), and endogenous ligands, such as anandamide, N-arachidonyl dopamine, and oleoyldopamine. AMG 9810 blocks capsaicin-evoked depolarization and calcitonin gene-related peptide release in cultures of rat dorsal root ganglion primary neurons. Screening of AMG 9810 against a panel of G protein-coupled receptors and ion channels indicated selectivity toward TRPV1. In vivo, AMG 9810 is effective at preventing capsaicin-induced eye wiping in a dose-dependent manner, and it reverses thermal and mechanical hyperalgesia in a model of inflammatory pain induced by intraplantar injection of complete Freund's adjuvant. At effective doses, AMG 9810 did not show any significant effects on motor function, as measured by open field locomotor activity and motor coordination tests. AMG 9810 is the first cinnamide TRPV1 antagonist reported to block capsaicin-induced eye wiping behavior and reverse hyperalgesia in an animal model of inflammatory pain.     

Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used.

To determine whether [2(3)H], [3(3)H], and [6(14)C]glucose provide an equivalent assessment of glucose turnover in insulin-dependent diabetes mellitus (IDDM) and nondiabetic man, glucose utilization rates were measured using a simultaneous infusion of these isotopes before and during hyperinsulinemic euglycemic clamps. In the nondiabetic subjects, glucose turnover rates determined with [6(14)C]glucose during insulin infusion were lower (P less than 0.02) than those determined with [2(3)H]glucose and higher (P less than 0.01) than those determined with [3(3)H]glucose. In IDDM, glucose turnover rates measured with [6(14)C]glucose during insulin infusion were lower (P less than 0.05) than those determined with [2(3)H]glucose, but were not different from those determined with [3(3)H]glucose. All three isotopes indicated the presence of insulin resistance. However, using [3(3)H]glucose led to the erroneous conclusion that glucose utilization was not significantly decreased at high insulin concentrations in the diabetic patients. [6(14)C] and [3(3)H]glucose but not [2(3)H]glucose indicated impairment in insulin-induced suppression of glucose production. These results indicate that tritiated isotopes do not necessarily equally reflect the pattern of glucose metabolism in diabetic and nondiabetic man.     

BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology

Histamine H3 receptor inverse agonists are known to enhance the activity of histaminergic neurons in brain and thereby promote vigilance and cognition. 1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride (BF2.649) is a novel, potent, and selective nonimidazole inverse agonist at the recombinant human H3 receptor. On the stimulation of guanosine 5'-O-(3-[35S]thio)triphosphate binding to this receptor, BF2.649 behaved as a competitive antagonist with a Ki value of 0.16 nM and as an inverse agonist with an EC50 value of 1.5 nM and an intrinsic activity approximately 50% higher than that of ciproxifan. Its in vitro potency was approximately 6 times lower at the rodent receptor. In mice, the oral bioavailability coefficient, i.e., the ratio of plasma areas under the curve after oral and i.v. administrations, respectively, was 84%. BF2.649 dose dependently enhanced tele-methylhistamine levels in mouse brain, an index of histaminergic neuron activity, with an ED50 value of 1.6 mg/kg p.o., a response that persisted after repeated administrations for 17 days. In rats, the drug enhanced dopamine and acetylcholine levels in microdialysates of the prefrontal cortex. In cats, it markedly enhanced wakefulness at the expense of sleep states and also enhanced fast cortical rhythms of the electroencephalogram, known to be associated with improved vigilance. On the two-trial object recognition test in mice, a promnesiant effect was shown regarding either scopolamine-induced or natural forgetting. These preclinical data suggest that BF2.649 is a valuable drug candidate to be developed in wakefulness or memory deficits and other cognitive disorders.     

Synthesis,FT-IR,structural, thermochemical,electronic absorption spectral,and NLO analysis of the novel 10-methoxy-10H-furo[3,2-g]chromeno[2,3-b][1,3]thiazolo[5,4-e]pyridine-2,10(3H)-dione (MFCTP): a DFT/TD-DFT study

Chemical transformation of 4-methoxy-5-oxo-5H-furo[3,2-g]chromene-6-carbonitrile (1) with 1,3-thiazolidine-2,4-dione (2) in boiling ethanol containing piperidine afforded the novel 10-methoxy-10H-furo[3,2-g]chromeno[2,3-b][1,3]thiazole[5,4-e]pyridine-2,10(3H)-dione (3, MFCTP). The chemical structure of the synthesized compound was established via elemental analysis and spectral data. FT-IR spectroscopy was performed in the range of 400–4000 cm⁻¹ for the vibrational spectral analysis of MFCTP. The GIAO method was employed to calculate the values of ¹H and ¹³C NMR chemical shifts theoretically, which were consistent with the experimental chemical shifts. The molecule (3, MFCTP) has two stable structures, as determined from the potential energy curve. The S1 structure is the most stable conformer of (3, MFCTP) according to the computational results. The density functional theory (DFT) and ab initio HF calculations and different basis set combinations based on the structure optimizations and normal coordinate force field were interpreted with the aid of the molecular structure, fundamental vibrational frequencies, and intensities of the vibrational bands. The potential energy distribution (PED) was determined based on the complete vibrational wavenumber assignments. The calculated spectra of the title compound were in agreement with the observed spectra. The scaled B3LYP/6-311++G(d,p) results exhibited better agreement with the experimental values compared to the other method used. The time-dependent density functional theory (TD-DFT) was employed to calculate the energy and oscillator strength and supplement the experimental findings. Also, it was performed and the results interpreted the molecular electrostatic potential, nonlinear optical and thermodynamic properties, and Mulliken and natural charges of the title compound. DFT calculations were performed to study the structure–activity relationship (SAR) and compared with the experimental antimicrobial results for compound (3, MFCTP).

A novel MFCTP was synthesized and characterized.     

Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse

Dopamine D(3) receptor partial agonism has been suggested as a potential therapeutic intervention in cocaine addiction. RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide] was identified as a novel selective dopamine D(3) receptor partial agonist and used for testing this hypothesis in animal models. The compound showed nanomolar affinity to human (K(i) = 6.7 nM) and rat (K(i) = 1.6 nM) D(3) receptors with an intrinsic activity of approximately 50%. It possessed several hundredfold selectivity over the D(2) receptor. The molecule bound with moderate (100-250 nM) affinity to 5-hydroxytryptamine 1A (5-HT(1A)) and nonselectively labeled opiate receptors. RGH-237 proved to be practically inactive on more than 40 other targets, including monoaminergic, cholinergic, GABAergic, and glutamatergic receptors. In rats orally administered RGH-237 was well and rapidly absorbed yielding 41% oral bioavailability. At its pharmacologically active dose (10 mg/kg p.o.), the brain concentration of RGH-237 reached 110 ng/g. Its blood and brain levels were sustained for 3 h. RGH-237 at the oral dose of 10 mg/kg moderately but significantly inhibited the acquisition of cocaine-induced place preference, although by itself, it had no place-conditioning effect. The compound did not affect fixed ratio 1 cocaine self-administration. In a reinstatement paradigm of cocaine self-administration, the compound potently and dose-dependently blocked the cue-induced cocaine-seeking behavior of rats at 10 and 30 mg/kg oral doses. RGH-237 did not affect seeking activity for natural rewards, such as sucrose and water. It did not exert notable effect on spontaneous motor activity of rats. Our results demonstrate that selective D(3) partial agonists may be an effective therapeutic means in the treatment of cocaine abuse.     

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo

The novel benzopyranopyrrolidine, S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], is a preferential antagonist of cloned human D(3) versus D(2L) and D(2S) receptors. In mice, S33138 (0.04-2.5 mg/kg i.p.) increased levels of mRNA encoding c-fos in D(3) receptor-rich Isles of Calleja and nucleus accumbens more potently than in D(2) receptor-rich striatum. Furthermore, chronic (3 weeks) administration of S33138 to rats reduced the number of spontaneously active dopaminergic neurones in the ventral tegmental area (0.16-10.0 p.o.) more potently than in the substantia nigra (10.0). In primates treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, antiparkinson actions of the D(3)/D(2) agonist, ropinirole, were potentiated by low doses of S33138 (0.01-0.16 p.o.) but diminished by a high dose (2.5). Consistent with antagonism of postsynaptic D(3)/D(2) sites, S33138 attenuated hypothermia and yawns elicited by the D(3)/D(2) agonist 7-OH-DPAT [(+)-7-dihydroxy-2-(di-n-propylamino)-tetralin] in rats, and it blocked (0.01-0.63, s.c.) discriminative properties of PD128,907 [(+)-(4aR,10bR)-3,4, 4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano-[4,3-b]-1,4-oxazin-9-ol; trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolininecarboxamide]. Suggesting antagonist properties at D(3)/D(2) autoreceptors, S33138 prevented (0.16-2.5 s.c.) the inhibitory influence of PD128,907 upon dopamine release in frontal cortex, nucleus accumbens, and striatum and abolished (0.004-0.25 i.v.) its inhibition of ventral tegmental dopaminergic neuron firing. At higher doses, antagonist actions of S33138 (0.5-4.0 i.v.) at alpha(2C)-adrenoceptors were revealed by an increased firing rate of adrenergic perikarya. Finally, antagonism of 5-hydroxytryptamine (5-HT(2A) and 5-HT(7)) receptors was shown by blockade of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane-induced head twitches (0.63-10.0 s.c.) and 5-carboxytryptamine-induced hypothermia (2.5-20.0 i.p.), respectively. In conclusion, S33138 displays modest antagonist properties at central alpha(2C)-adrenoceptors, 5-HT(2A) and 5-HT(7) receptors. Furthermore, in line with its in vitro actions, it more potently blocks cerebral populations of D(3) versus D(2) receptors.     

Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe

A novel in vivo binding test was developed in order to evaluate the degree of occupancy of enkephalinase (EC 3.4.24.11), a membrane-bound metallopeptidase, in cerebral and peripheral tissues of mice treated with enkephalinase inhibitors. The probe selected for this purpose was the prodrug [3H]acetorphan, a lipophilic diesterified derivative of the potent enkephalinase inhibitor thiorphan readily releasing the latter by tissue hydrolysis. In order to validate the in vivo binding assay, [3H]thiorphan binding to membranes was first studied in vitro. [3H]Thiorphan binding to cerebral and peripheral tissues (lung and kidney) was saturable over a low nonspecific binding, occurring with a KD of 0.6 nM consistent with the Ki of the compound as enkephalinase inhibitor. [3H]Thiorphan binding varied largely among various tissues and was highly correlated with the catalytic activity of enkephalinase, thus indicating a selective labeling of the peptidase. After the i.v. administration of [3H]acetorphan a large fraction of the radioactivity remained bound to membranes isolated by a rapid filtration assay. Bound radioactivity mainly corresponded to [3H] thiorphan as identified by high-performance liquid chromatography analysis of kidney membranes, whereas unchanged [3H]acetorphan was not detectable. In vivo binding generated by [3H]acetorphan was saturable, with maximum binding sites values which were in rather good agreement with corresponding maximum binding sites values of [3H]thiorphan binding in vitro, particularly in brain. Specific in vivo binding was calculated as the difference between total and a generally low, nonspecific binding evaluated in mice receiving a large dose of nonlabeled acetorphan. Specific in vivo binding varied largely among tissues and generally reflected the abundance of enkephalinase molecules in the latter.(ABSTRACT TRUNCATED AT 250 WORDS)     

Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs

Analogs of benztropine (BZT) bind to the dopamine (DA) transporter and inhibit DA uptake but often have behavioral effects that differ from those of cocaine and other DA-uptake inhibitors. To better understand these differences, we examined the relationship between locomotor-stimulant effects of cocaine, 1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)-piperazine (GBR 12909), and BZT analogs [(3alpha-[bis(4'-fluorophenyl)methoxy]-tropane) (AHN 1-055) and (N-allyl-3alpha-[bis(4'-fluorophenyl)methoxy]-tropane) (AHN 2-005)] and their in vivo displacement of the DA transporter ligand [125I]3beta-(4-iodophenyl)-tropan-2beta-carboxylic acid isopropyl ester hydrochloride (RTI-121) in striatum. Cocaine, GBR 12909, and BZT analogs each displaced [125I]RTI-121 and stimulated locomotor activity in a dose- and time-dependent manner. The time course revealed a slower onset of both effects for AHN 1-055 and AHN 2-005 compared with cocaine and GBR 12909. The BZT analogs were less effective than cocaine and GBR 12909 in stimulating locomotor activity. Locomotor stimulant effects of cocaine were generally greater than predicted by the regression of displacement of [125I]RTI-121 and effect at short times after injection and less than predicted at longer times after injection. This result suggests that the apparent rate of occupancy of the DA transporter, in addition to percentage of sites occupied, contributes to the behavioral effects of cocaine. The present results suggest that among drugs that act at the DA transporter, the slower apparent rates of occupancy with the DA transporter by the BZT analogs may contribute in an important way to differences in their effectiveness.     

Design,characterization and catalytic evaluation of halometallic ionic liquid incorporated Nd2O3 nanoparticles ([smim][FeCl4]−@Nd2O3) for the synthesis of N-aryl indeno pyrrole derivatives

Silica modified imidazolium [smim] based halometallic ionic liquids, [smim][MCl₄] (M = Fe, Cu and Zn), were synthesized for the evaluation of acidic and catalytic properties. Among these ILs, [smim][FeCl₄]⁻ was used for the preparation of heterogeneous catalyst ([smim][FeCl₄]⁻@Nd₂O₃) by simple immobilization of IL on Nd₂O₃ nanoparticles. The structure of [smim][FeCl₄]⁻@Nd₂O₃ was established by various techniques including FTIR, Raman, UV-vis DRS, powder XRD, SEM/EDX, elemental mapping, TEM, TGA, EPR and XPS analyses. The stability of nano-catalyst, [smim][ FeCl₄]⁻@Nd₂O₃, was established with the help of zeta potential analysis which showed a value of −40.32 mV lying under the stability range. Potentiometric titration with n-butyl amine was used to evaluate the acidic properties of [smim][MCl₄] as well as [smim][FeCl₄]⁻@Nd₂O₃. The catalytic potential of the material was probed through the one pot synthesis of N-aryl indeno pyrrole derivatives. The results showed excellent performance of the material by producing a high yield (98%) of indeno pyrrole derivatives. A recyclability experiment revealed that the catalyst was efficient in up to five cycles with insignificant loss in catalytic activity. The evaluation of green metrics indicated the sustainability of the present protocol in terms of high atom economy and low E-factor.

Silica modified imidazolium based halometallic ionic liquids, [smim][MCl₄] and [smim][FeCl₄]⁻@Nd₂O₃ were synthesized for the evaluation of acidic and catalytic properties.     

S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol

S-16924 is a potential antipsychotic that displays agonist and antagonist properties at serotonin (5-HT)1A and 5-HT2A/2C receptors, respectively. In a pigeon conflict procedure, the benzodiazepine clorazepate (CLZ) increased punished responses, an action mimicked by S-16924, whereas the atypical antipsychotic clozapine and the neuroleptic haloperidol were inactive. Similarly, in a Vogel conflict paradigm in rats, CLZ increased punished responses, an action shared by S-16924 but not by clozapine or haloperidol. This action of S-16924 was abolished by the 5-HT1A antagonist WAY-100,635. Ultrasonic vocalizations in rats were inhibited by CLZ, S-16924, clozapine, and haloperidol. However, although WAY-100,635 abolished the action of S-16924, it did not affect clozapine and haloperidol. In a rat elevated plus-maze, CLZ, but not S-16924, clozapine, and haloperidol, increased open-arm entries. Like CLZ, S-16924 increased social interaction in rats, whereas clozapine and haloperidol were inactive. WAY-100,635 abolished this action of S-16924. CLZ, S-16924, clozapine, and haloperidol decreased aggressive interactions in isolated mice, but this effect of S-16924 was not blocked by WAY-100, 635. All drugs inhibited motor behavior, but the separation to anxiolytic doses was more pronounced for S-16924 than for CLZ. Finally, in freely moving rats, CLZ and S-16924, but not clozapine and haloperidol, decreased dialysis levels of 5-HT in the nucleus accumbens: this action of S-16924 was blocked by WAY-100,165. In conclusion, in contrast to haloperidol and clozapine, S-16924 possessed a broad-based profile of anxiolytic activity at doses lower than those provoking motor disruption. Its principal mechanism of action was activation of 5-HT1A (auto)receptors.     

Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester

NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester] is an NO-releasing flurbiprofen derivative that also contains a ferulic acid (antioxidant) moiety. NCX-2216 has been shown to be effective in reducing beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. The tolerability of this compound in the stomach and its ability to suppress prostaglandin synthesis in the brain are not known. The purpose of this study was to assess the contribution of nitric oxide (NO) and ferulic acid to the pharmacological properties of NCX-2216 versus flurbiprofen; thus, we compared their gastric tolerability and suppression of prostaglandin synthesis, peripherally and centrally. Oral flurbiprofen produced extensive gastric damage and suppressed gastric prostaglandin synthesis. In contrast, while suppressing prostaglandin production, equimolar doses of NCX-2216 did not cause detectable gastric injury. The NO-releasing moiety of NCX-2216 (but not the ferulic acid moiety) was crucial for the gastric safety of this compound. NCX-2216 substantially inhibited prostanoid synthesis despite not being detectable in plasma and despite producing only low amounts of flurbiprofen in plasma and in the brain. Inhibition of brain prostaglandin synthesis by NCX-2216 (22 mg/kg) persisted for a much longer period of time (up to 48 h) than was seen with flurbiprofen (相似文献   

Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice

A mouse model of atypical antipsychotic-associated adverse effects was used to compare the liability to induce weight gain, food intake, and metabolic alterations after chronic olanzapine (OL; LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5] benzodiazepine) and ST2472 (ST; 9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine) administration. By adding two equipotent doses (3 and 6 mg/kg) of either OL or ST to a high-sweet, high-fat (HS-HF) diet, mice were allowed to self-administer drugs up to 50 days. Body weight and food intake were evaluated daily. Locomotor activity was recorded over 48 h at two different time points. Dyslipidemia was measured by central visceral obesity. Blood serum levels of insulin (IN), glucose (Glu), triglycerides (TGs), nonesterified fatty acids (NEFAs), cholesterol (Ch), and ketone (Ke) bodies were quantified. OL treatment at 3 mg/kg enhanced body weight, whereas at the highest dose, the increase became evident only during the last 10 days of treatment. OL (3 mg/kg) increased HS-HF intake over time, whereas the highest dose reduced intake during the second 10 and final 10 days of administration. Both compounds induced nocturnal hypomotility at the highest dose. In contrast to ST, 3 mg/kg OL elevated serum levels of IN, Glu, TG, NEFA, Ch, and Ke, whereas 6 mg/kg OL elevated those of Glu, TG, and Ch. In contrast, ST did not affect weight gain, food intake, and metabolic markers. Given the similarities between OL-induced obesogenic effects and medical reports, this study further supports the view that ST may represent a new class of agents characterized by a low propensity to induce side effects with promising clinical safety.